Recombinant CA9 anticorps (Extracellular, N-Term)

N° du produit ABIN7876852

Cet anticorps anti-CA9 Monoclonal Souris (Clone rCA9-9937) (ABIN7876852) détecte spécifiquement CA9 dans WB et IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour Recombinant CA9 anticorps (Extracellular, N-Term) (ABIN7876852)

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CA9 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RCA9-9937

Détail du produit anti-CA9 anticorps

Épitope: AA 80-100, Extracellular, N-Term

Fonction: Recombinant CA9 Antibody / Carbonic anhydrase 9

Purification: Protein G affinity

Immunogène: The extracellular N-terminal proteoglycan-like region of the human protein was used as the immunogen for the recombinant CA9 antibody. The epitope is localized to the amino acids 80-100 region.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant CA9 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant CA9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur CA9

Antigène: CA9 (Carbonic Anhydrase IX (CA9))

Autre désignation: CA9

Sujet: Recognizes a glycoprotein of ~200 kDa, identified as carbonic anhydrase IX (CAIX/gp200).In normal kidney, gp200 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, gp200 is expressed by 93 % of primary and 84 % of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.

UniProt: Q16790